Mitsuji Yamashita1, Hiroko Hasegawa1, Michio Fujie2, Satoki Nakamura2, Reiko Makita1, Junko Yamashita1, Tatsuo Oshikawa3, Mitsuru Kondo1, Mitsuo Toda1, Kazunori Ohnishi2 and Haruhiko Sugimura2
MarÃÂa Laura Lavaggi, Maira de Negri, Alicia Merlino and LucÃÂa Minini
Victor J Hruby, Minying Cai, Kaitlyn McLeod and Yang Zhou
Kal Ramnarayan
Hesham Haffez1, 2, Ehmke Pohl1, Christopher Redfern2 and Andrew Whiting1
How close are we to predicting binding affinity?
Carsten Detering
Ligand-based screening for anti-dengue virus inhibitor
Tatsuya Takagi, Norihito Kawashita, Yu-shi Tian, Sabar Pambudi, Teruo Yasunaga, Kazuyoshi Ikuta and Takeshi Kurosu
Nanoparticles with novel methodology to treat infectious diseases
Prabagaran Narayanasamy
Exploring for bioactive secondary metabolites from the Chinese medicinal mangroves
Yue-Wei Guo
Alessandra Nurisso
Development of new antibiotics targeting shikimate kinase: From concept to practice
Concepción González-Bello
Amylin as a Novel Contributor to Alzheimer’s Disease and Natural Product Inhibitor Discovery
Bin Xu
Discovery of novel orexin-1 selective antagonists using NMR guided conformational design
Thorsten Nowak, Barrie Martin, Martin Watson and Charles Blundell
Hamed I Ali1,2, Walaa A Bedewy2, Ahmed M Abdelhameed2, Mosaad S Mohamed2, Mohamed A Elsawy3 and Tomohisa Nagamatsu4
The mode of action of new promising anticancer agents: Multifunctional polymer-ruthenium conjugates
Andreia Valente1, M H Garcia1, A Pilon1, A P Matos1, F Tortosa1, 2, N Mendes3, F Gärtner3, A Preto4, R Francisco1, 4, B T Buckley5 and F Marques1
Epi-drug development targeting human G9a H3K9 methyltransferase
Yong-Hwan Lee
Nitrones as potential therapeutic agents against Alzheimer’s disease
Alicia Merlino1, Saira Cancela1,2, Paola Hernández2, Gustavo Mourglia-Ettlin1 and Williams Porcal1
Small-molecule modulators of thiamine transport in pathogenic bacteria
Anna K H Hirsch
Yanli Wang
Ruthenium drugs for cancer therapy: Small structural changes, different in vivo performances
M Helena Garcia1, Tânia S Moraisa1, A Isabel Tomaz1, Fernanda Marques2 and Andreia Valente1
Jonathan S Foot
Carlos H Castaneda1, Terri G Edwards2, Edith Csiki-Fejer1, M José Scuderi1, Kevin J Koeller1, G Davis Harris Jr1, Gaofei He1, Silke Evdokimov1, Faten Tamimi1, Elena Vasilieva1, Cynthia M Dupureur1, Chris Fisher2 and James K Bashkin1, 2
Ekta Rawat
Development of a novel class of hyper-multi-targeted computer-aided CREKA/YIGSR
Ioannis Grigoriadis
Najat Farsi
TAAR1 ligands as prospective neuroleptics: From D-neuron research
Keiko Ikemoto
Medicinal Chemistry received 6627 citations as per Google Scholar report